Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells-Reference-Cited by-同舟云学术

Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells

Published:2020-07-21 Issue:10 Volume:60 Page:2389-2398
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Geisen Christof¹^ORCID,North Anne²,Becker Lisa¹,Brixner Veronika¹^ORCID,Goetz Melissa²,Corash Laurence²^ORCID,Benjamin Richard J.²^ORCID,Mufti Nina²,Seifried Erhard¹^ORCID

Affiliation:

1. Institute of Transfusion Medicine and Immunohaematology, German Red Cross Blood Transfusion Service Baden‐Württemberg‐Hessen gGmbH Goethe University Hospital Frankfurt/Main Frankfurt am Main Germany

2. Cerus Corporation Concord California USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15965

Reference22 articles.

1. Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment

2. Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process

3. Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates

4. Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study

5. Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study—protocol for a phase 3, randomized, controlled trial;Trials;2023-12-11

2. Analysis of genetic test results in 378 patients suspected of thalassaemia;Biotechnology and Genetic Engineering Reviews;2023-05-24

3. New ultraviolet C light‐based method for pathogen inactivation of red blood cell units;Transfusion;2022-09-10

4. Commentary on the 1985 transfusion paper by Horowitz, Wiebe, Lippin, and Stryker;Transfusion;2022-08